Meta description: A new trial comparing an erector spinae plane block with transcutaneous radiofrequency for postherpetic neuralgia signals regulatory interest in device assisted pain management and study transparency.
A new clinical trial led by Diskapi Teaching and Research Hospital is evaluating an erector spinae plane block as a treatment option for postherpetic neuralgia. The trial description indicates the intervention is a procedure named erector spinae plane block and the comparator is transcutaneous radiofrequency energy. The trial targets patients with postherpetic neuralgia and related neuropathic pain conditions linked to herpes zoster. The study status is Recruiting and the record is listed on ClinicalTrials.gov under NCT07400640. This overview is intended for regulatory and clinical teams reviewing device related research as of February 11 2026.
What changed for postherpetic neuralgia device research
The record confirms an intervention that compares the erector spinae plane block with transcutaneous radiofrequency therapy in patients with postherpetic neuralgia. The sponsor is Diskapi Teaching and Research Hospital. The trial is listed on ClinicalTrials.gov with the identifier NCT07400640 and is currently recruiting. The inclusion criteria reference conditions such as postherpetic neuralgia neuropathic pain and herpes zoster. The study focuses on device mediated procedures for pain management and their safety and potential benefits. At this time there are no published results in the source text; the role of the device in question will depend on trial outcomes and regulatory review.
Intervention under study
The erector spinae plane block is a regional anesthesia technique used to target the dorsal rami of the spinal nerves. In this trial it is studied as a potential option for pain relief in postherpetic neuralgia. The trial compares this block to transcutaneous radiofrequency energy delivered to nearby tissue in an effort to reduce pain intensity and improve function. The study record does not provide efficacy results in the source text.
How is the study designed and who is involved
The sponsoring site listed is Diskapi Teaching and Research Hospital. The trial is described as a procedure based comparison between two approaches for neuropathic pain. The primary aim appears to be evaluating safety and feasibility in a real world clinical context. Because this is a registry entry the exact sample size endpoints and statistical analysis plan are not detailed in the source text. Stakeholders include the treating clinicians and the sponsoring hospital as well as regulatory bodies that oversee device studies.
What are the safety and performance considerations for this comparison
Safety considerations for the erector spinae plane block include standard regional anesthesia risks such as infection bleeding and unintended nerve injury. For transcutaneous radiofrequency energy considerations include the risk of tissue heating and device related adverse events. The source text does not report results; readers should await trial data and regulatory assessment before drawing conclusions about safety and performance. This context will inform how the medical device and its use in pain management may be represented in regulatory submissions.
What are the regulatory implications for devices in this trial
Regulatory professionals will watch for how the intended use and performance claims are defined in the trial records. The MDR style emphasis on patient safety risk management device labeling and post market surveillance applies to any device involved in this trial. Clear documentation of procedure indications risk controls and training will support regulatory review. The presence of a direct comparator within a trial may influence how devices are evaluated in future submissions and guidelines for data interpretation.
Who should care and how should they respond
Clinicians treating postherpetic neuralgia may see new device guided options in the future. Device developers and sponsors will monitor trial progress and plan regulatory submissions based on outcomes and safety data. Regulators will assess the study for compliance with clinical trial and device regulations and consider how this information translates to labeling and therapeutic guidelines. Patients with nerve related pain and their care teams may benefit from emerging evidence once results are published and validated.
- 1. What is erector spinae plane block
An erector spinae plane block is a procedure that involves injecting a local anesthetic in a plane near the spine to modulate pain signals. - 2. What is transcutaneous radiofrequency
Transcutaneous radiofrequency is a device guided energy therapy intended to alter pain signaling or tissue response through controlled heat. - 3. What is the current status of the trial
The source text lists the study as recruiting and registered on ClinicalTrials.gov with the number NCT07400640. - 4. Where can I find the official study record
The official record is on ClinicalTrials.gov at the link provided in the source: https://clinicaltrials.gov/study/NCT07400640?term=medical+device
Conclusion and next steps the trial overview confirms a direct comparison of a block technique against a transcutaneous energy therapy in a postherpetic neuralgia patient population. Regulatory watchers should track recruitment outcomes device safety data and any future publications. Practitioners should await results and maintain adherence to current standards of care until validity is established.
Disclaimer: This information is intended for professionals. It is not legal advice and does not constitute regulatory guidance. Consult qualified counsel for regulatory decisions.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07400640?term=medical+device